Ignite Creation Date:
2024-10-26 @ 3:43 PM
Last Modification Date:
2024-10-26 @ 3:43 PM
Study NCT ID:
NCT06649877
Status:
COMPLETED
Last Update Posted:
None
First Post:
2024-10-17
Brief Title:
MK-6194 Site of Injection Study in Healthy Adult Participants MK-6194-013
Sponsor:
None
Organization:
None
Study Overview
Official Title:
A Randomized Clinical Study to Evaluate the Impact of Injection Site Thigh vs Abdomen on the Pharmacokinetics and Relative Bioavailability of Subcutaneously Injected MK-6194 in Healthy Adult Participants
Status:
COMPLETED
Status Verified Date:
2024-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The goal of this study is to learn what happens to MK-6194 in a healthy persons body when different injection sites are used Researchers will compare what happens to MK-6194 in a healthy persons body when it is injected into the abdomen and when it is injected into the thigh Researchers think that the average amount of MK-6194 in a persons body over time will be similar when injected into the thigh or abdomen They also want to learn if it is safe to inject MK-6194 into the abdomen and thigh and if people tolerate it
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None